Tag: News Releases

Global pharmaceutical industry welcomes new collaborative platform
Study on access to essential HIV/AIDS treatments shows political will as most important factor
Global pharmaceutical industry contributes action plan and research to fighting NCDs in the developing world
IFPMA announces Biogen Idec Inc. as new member
IFPMA announces Lundbeck and Innovative Pharma as new members
IFPMA welcomes Otsuka Pharmaceutical as new member to advance global health
Research-based pharmaceutical industry launches collaborative framework to tackle NCDs
Research-based pharmaceutical industry welcomes WHA outcome on vaccines, fake medicines and NCDs
Research-based pharmaceutical industry welcomes main conclusions of 2009 flu pandemic response
R&D pharmaceutical industry attends the 64th World Health Assembly
Russians evidently overestimate their state of health as good and fair
IFPMA supports principles of pandemic influenza preparedness decision
IFPMA supports WHO world health day: new efforts needed to combat AMR
Research-based pharmaceutical industry emergency aid for Japan earthquake and tsunami victims
Technology transfer: A collaborative approach to improve global health
IFPMA supports call for extension of TRIPS compliance deadline for least developed countries
IFPMA announces Amgen as new member company
IFPMA companies undertaking 100+ R&D projects for diseases of the developing world
Mr. David Brennan of AstraZeneca elected president of IFPMA
25th IFPMA assembly explores theme of “A shared commitment to global health”
Research-based pharmaceutical industry aid to Pakistan amounts to more than USD 3.3 million
IFPMA President calls on industry to continue MDG contributions beyond 2015
IFPMA study shows low overall seasonal influenza vaccine distribution, despite recent growth
IFPMA & WADA to cooperate in the fight against doping in sport
UN General Assembly informed of R&D pharmaceutical industry’s substantial contributions to millennium development goals
New industry position requires submission for journal publication of all phase III clinical trials
IFPMA launches ten principles on counterfeit medicines
Launch of IFPMA developing world health partnerships directory 2010
Haiti: research-based pharmaceutical industry emergency aid exceeds USD 16.9 million
1 2 3

Other Tags

Access Access to antiretrovirals Access to Medicines Access to vaccines Africa AMR AMR Industry Alliance Anti-Counterfeit Antibiotics antimicrobial resistance antivirals Biosimilars Biotherapeutic Medicines Biotherapeutics Cancer Clinical Trials Code of Practice collaboration Counterfeit Medicines Counterfeits COVID-19 COVID-19 vaccines Dementia Developing World Diabetes Economic footprint Epidemics Ethics Event Highlights Fake Medicines Fakes Falsified Medicines Fight the Fakes Flu Global Health global health security harmonization Health Health Partnerships HIV/AIDS IFPMA IFPMA Assembly IFPMA Statement Immunization Incremental Innovation Influenza Infographic Infographics Innovation Innovation ecosystem Intellectual Property IP Malaria MDGs Medicines Mental and Neurological Disorders NCDs Neglected Tropical Diseases News Releases Non-Communicable Diseases Novel Coronavirus (COVID-19) NTDs pandemic Pandemic Influenza Pandemic preparedness pandemics partnership Partnerships Pharma Pharmacovigilance Position Paper Prevention Publications Public Health Quality R&D Regulatory regulatory systems Related Links Research Safety SDGs Seasonal Influenza Statements Supply chain Sustainable Development Goals Sustainable Innovation trade Treatments Tuberculosis UHC Universal Health Coverage Vaccine Vaccines Value of Innovation Videos WHA WHO WIPO Women’s Cancers